- District-level wholesale fertilizer license in Karnataka. Through the Seva Sindhu portal, eligible applicants can submit applications, upload necessary documents, and comply with Fertilizer Control Order provisions. The license authorizes wholesale fertilizer distribution within a specific district, ensuring regulated supply, quality control, and legal compliance in fertilizer trade to support farmers effectively.
- Allows existing manufacturers to renew their manufacturing license for micro nutrients mixture fertilizers in Karnataka. Through the Seva Sindhu portal, applicants can submit renewal requests before license expiry, upload updated documents, and comply with regulatory requirements under the Fertilizer Control Order. The digital process ensures continuity of operations, minimizes delays, and helps manufacturers legally continue fertilizer production without interruptions.
- Manufacturers in Karnataka to apply online for the issue of a manufacturing license for micro nutrients mixture fertilizers through the Seva Sindhu portal. It ensures compliance with Fertilizer Control Order (FCO) regulations and quality standards. Applicants can submit required documents, track application status, and receive approvals digitally, promoting transparency, efficiency, and timely authorization for lawful fertilizer production supporting agricultural productivity.
- Village Level Entrepreneur (VLE), Want to know the status of your application! Enter the details and proceed the user will be able to work on Digital Seva Portal and will be able to deliver various government and non-government services. Become a part of the Digital India programme, and work as a Village Level Entrepreneur.
- This online service facilitates applications for a Schedule-X Retail Licence in Uttar Pradesh, allowing authorized pharmacies to sell controlled medicines listed under Schedule-X. The process ensures strict compliance with safety, storage, and record-keeping norms. Through a streamlined digital system, applicants can submit documents, track application status, and obtain approvals efficiently, supporting regulated retail distribution of sensitive pharmaceutical products.
- This service enables wholesalers to apply for a licence to distribute drugs listed under Schedule-X in Uttar Pradesh. These medicines are subject to strict regulatory controls due to their sensitive nature. The portal ensures secure online registration, documentation, and compliance with statutory guidelines. It supports responsible wholesale operations while maintaining traceability, safety, and adherence to legal standards prescribed by drug regulatory authorities.
- This service allows applicants to obtain a Drugs Restricted Licence in Uttar Pradesh for the sale of specific medicines under regulated conditions. It is designed for establishments permitted to sell a limited range of drugs without a full retail licence. The online platform ensures proper documentation, regulatory compliance, and efficient processing, helping applicants meet legal requirements while maintaining controlled and responsible drug distribution practices.
- This online facility enables individuals and businesses to apply for a Drugs Retail Licence in Uttar Pradesh. It is intended for pharmacies and medical stores selling medicines directly to consumers. The portal simplifies the application process by allowing digital submission of forms and documents while ensuring compliance with statutory norms. It promotes regulated retail drug sales, enhances accountability, and supports timely approval for eligible applicants within the state.
- This service facilitates the application for a Drugs Wholesale Licence in Uttar Pradesh for businesses involved in the wholesale distribution of pharmaceutical products. Applicants can register online, submit mandatory documents, and comply with regulatory requirements under the Drugs and Cosmetics Act. The system ensures transparency, faster processing, and ease of compliance. It is suitable for distributors, suppliers, and pharmaceutical firms aiming to legally operate and expand wholesale drug…
- This online service allows applicants to obtain a licence for the collection, storage, and processing of whole human blood and its components for sale or distribution in Uttar Pradesh. It ensures adherence to safety, quality, and regulatory norms prescribed by authorities. The portal provides a single-window system for registration, submission of required documents, and monitoring application status, simplifying the licensing process for healthcare institutions and blood bank operators.
- This service enables applicants to apply for the grant or renewal of a licence to operate a blood bank in Uttar Pradesh. It covers permissions for processing whole blood and preparing blood components in compliance with regulatory standards. The online portal streamlines registration, document submission, and application tracking, ensuring transparency and efficiency. It is intended for hospitals, medical institutions, and authorized organizations seeking to maintain safe, regulated, and legally…
- This service facilitates online applications for approval of raw materials used in manufacturing drugs or cosmetics on behalf of a licensed producer. Applicants can submit documentation, verify compliance requirements, and track approvals seamlessly through the portal. The system ensures that only safe and authorized raw materials are used in production, maintaining product quality and regulatory standards. It supports manufacturers by offering a transparent, efficient process that strengthens oversight…
- This service enables applicants to apply for a loan licence to manufacture cosmetics using another authorized manufacturer’s facilities. The online portal simplifies the application process, allowing users to upload documents, comply with regulatory norms, and track approval status efficiently. This facility supports small and medium enterprises that rely on outsourced manufacturing while ensuring adherence to quality and safety regulations. The system promotes transparency, accountability, and…
- This portal offers a convenient online platform for applying for a licence to manufacture cosmetics in Uttar Pradesh. Users can submit required documents, complete regulatory formalities, and monitor application progress digitally. The service ensures that cosmetic manufacturers adhere to quality and safety standards as prescribed by the Drugs and Cosmetics Act. By simplifying procedures and enhancing transparency, the portal supports entrepreneurs and industries involved in producing beauty and…
- This service allows applicants to obtain a manufacturing licence specifically for producing drugs meant for examination, testing, or analytical purposes. Through the online portal, users can submit applications, upload mandatory documents, pay fees, and track the approval workflow. This facility ensures regulatory compliance while supporting laboratories, research institutions, and manufacturers involved in drug testing. The streamlined digital process promotes transparency, efficiency, and ease…
- This service enables manufacturers to apply for licences to produce specialized biological products such as large-volume parenterals, vaccines, sera, and recombinant DNA-based drugs listed under Schedules C and C(1), excluding Schedule X. The portal provides a streamlined process for documentation, compliance verification, and tracking approvals. It ensures adherence to high safety and quality standards while supporting advanced pharmaceutical and biotechnological manufacturing in Uttar Pradesh.
- This portal offers an online facility to apply for manufacturing licences for drugs falling under Schedules C, C(1), and X, which require strict regulatory oversight. Applicants can upload documents, meet safety and quality criteria, and track application progress digitally. By ensuring compliance with stringent norms, the service supports responsible manufacturing and enhances efficiency, transparency, and accountability in the pharmaceutical sector of Uttar Pradesh.
- This service enables applicants to apply for a loan licence to manufacture Schedule C and C(1) drugs, excluding Schedule X, using another firm’s licensed facilities. The portal simplifies form submission, document uploads, and monitoring of approval stages. It ensures regulatory compliance while supporting businesses that prefer outsourcing production. The system enhances transparency and operational ease for pharmaceutical units operating within Uttar Pradesh.
- Through this portal, manufacturers can apply for licences to produce drugs listed under Schedules C and C(1), excluding those under Schedule X. These drugs often require specific storage and production standards. The system enables online submission, verification, and tracking, ensuring adherence to quality and safety regulations. It supports pharmaceutical manufacturers by offering a streamlined, transparent, and efficient process for obtaining required permissions in Uttar Pradesh.
- This service allows pharmaceutical units to apply for licences to manufacture Schedule X drugs that do not fall under Schedules C and C(1). Schedule X drugs require stringent control due to their potential for misuse. The portal ensures secure digital submission of applications, compliance checks, and progress tracking. It promotes responsible manufacturing by enforcing strict regulatory guidelines while supporting businesses in meeting statutory requirements.
TIMES UPDATE
- by Supriya RoyJioMart is poised to become India's second-largest quick commerce player, Reliance announced, highlighting significant growth with 1.6 million daily orders in Q4. The platform expanded its reach to 5,000 pin codes, adding millions of new customers. This surge intensifies competition as rivals like Blinkit and Swiggy Instamart prepare their results, with market share becoming a […]
- by TOI Business DeskTata Motors is urging the government to consider targeted incentives for entry-level electric vehicles and fleet electric cars in the upcoming Union Budget. The company believes these measures, alongside existing support, are crucial for boosting EV adoption and reducing environmental impact, especially as entry-level EVs face significant price pressure.
- by TOI Business DeskParle Products saw revenue rise in FY25 but profitability declined amid fierce competition. Britannia Industries remained the largest biscuit maker. Mondelez India Foods also experienced a revenue drop. The Indian biscuit market is valued at over a lakh crore and is projected to grow significantly. Regional players are also expanding their reach.
- by TOI Business DeskA report by Genius HRTech reveals a significant gap between AI adoption and corporate training, with 71% of professionals anticipating role changes due to AI. Despite widespread AI usage for efficiency, 61% of employees report inadequate organizational guidance, and only 37% have received proper training.
- Even with external uncertainties lingering, the Indian economy is expected to record healthy growth of 7 per cent in the upcoming financial year 2026-27, CareEdge Ratings has asserted.
- by TOI Business DeskGold prices are poised to continue their upward trajectory, fueled by safe-haven demand and anticipated US Federal Reserve policy easing. Meanwhile, silver may experience a consolidation phase after a significant recent rally. Analysts are closely monitoring global economic data and geopolitical developments for further market direction.
- by TOI Business DeskA new wave of Indian entrepreneurs, dubbed BARBIEs (Bachelors Abroad Returning to Build in the Indian Ecosystem), are returning from US undergraduate studies to launch high-growth companies. These founders, often from privileged backgrounds, leverage their global exposure and early independence to build businesses in sectors like quick commerce and fintech, driven by India's massive scale […]
- by TOI Business DeskTeam India is making a strong pitch at Davos, urging global partners to "subscribe to the future" by investing in Bharat and collaborating on technology. The India Pavilion highlights investment opportunities, with IT majors showcasing AI advancements. Over 100 Indian CEOs and several state delegations are present, promoting India's economic potential to over 3,000 global […]
- by TOI Business DeskFrance will ask the EU to activate its anti-coercion instrument against potential US tariffs over Greenland. President Macron stated the threat is unacceptable and Europe will not be intimidated. The tool, a trade 'bazooka,' allows the bloc to curb imports or market access in response to economic coercion.
- by TOI Business DeskEbru Ozdemir, a prominent figure in the engineering and construction sector, asserts that empowering women in the workforce is the most effective strategy for building a robust, inclusive, and future-ready economy. She emphasizes that gender-focused reskilling and upskilling are vital for the digital age, and integrating women into STEM fields is crucial for tackling global […]
- by TOI Business DeskThe IT industry body MAIT has urged the government to slash basic customs duty on key electronic components and boost tax incentives in the upcoming Union Budget. This move aims to strengthen domestic manufacturing, improve global competitiveness, and address supply chain vulnerabilities amid rising global uncertainties. MAIT also called for continued support for mobile manufacturing.
- by TOI World DeskThe UAE has implemented a new minimum wage per month for private-sector employees in the Emirates, effective January 1, 2026. This policy aims to bolster Emiratisation efforts and strengthen labour standards. Companies must comply by June 30, 2026 or face penalties, marking a significant shift in the nation's labour market.
- Sumadhura Group is set to invest approximately Rs 6,000 crore in developing six new housing projects across Bengaluru. These projects will offer over 4,000 units, including apartments and residential plots, spread across 90 acres. The company anticipates a total revenue of around Rs 10,000 crore from these upcoming developments.
- by TOI Business DeskA report by China Labor Watch revealed exploitative practices at a factory producing popular Labubus dolls for Pop Mart. The factory allegedly hired underage workers without proper protections and forced employees to sign blank contracts. Workers also faced unrealistic production targets and excessive overtime, exceeding legal limits significantly.
- by TOI Business DeskIndian businesses are feeling more optimistic, with the CII Business Confidence Index hitting a five-quarter high. Strong domestic demand, boosted by GST cuts and festive spending, is driving this positive outlook. Firms anticipate further demand growth and robust investment and hiring intentions, signaling continued economic momentum.
- by TOI Business DeskAs the Union Budget 2026-2027 approaches, market participants are urging the government to avoid increasing transaction taxes and instead offer relief on long-term capital gains from equity investments. Stakeholders advocate for a higher tax-free exemption limit and a uniform definition of 'long term' to encourage retail investors.
- by TOI Business DeskIndian pharmaceutical exports are experiencing robust growth in emerging markets like Brazil and Nigeria, driven by increased healthcare access and demand for generics. Despite global economic headwinds, these nations are becoming crucial destinations, contributing significantly to India's overall pharma export expansion and strengthening its global market position.
- by TOI Business DeskAhead of the 2026-27 Union Budget, ICRA anticipates a dual focus on medium-term debt reduction and robust capital expenditure. The budget, aligning with the 16th Finance Commission, aims for a fiscal deficit of 4.3% of GDP. Significant infrastructure spending is expected, with capital expenditure projected to rise by 14% to Rs 13.1 trillion, before potential […]
- by Shivanghi PayalTrump's threat to impose tariffs on European allies over Greenland has reignited debate on his tariff strategy. These tariffs are increasingly seen as harming US jobs, keeping inflation high, straining alliances, and failing to curb China's exports, despite revenue gains.
- by TOI Business DeskDespite a flat broader market, State Bank of India and Infosys propelled a Rs 75,855 crore gain in the market capitalisation of three top Indian firms. While Reliance Industries and Larsen & Toubro saw significant drops, Infosys's boosted guidance offered a positive outlook for IT stocks. The top ten companies' rankings remained unchanged.